(TU) Telus - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA87971M1032
Stock: Telecommunications, Technology, Health, Digital, Security
Total Rating 25
Risk 65
Buy Signal -1.32
| Risk 5d forecast | |
|---|---|
| Volatility | 18.0% |
| Relative Tail Risk | -2.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -11.40 |
| Character TTM | |
|---|---|
| Beta | 0.119 |
| Beta Downside | 0.133 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.43% |
| CAGR/Max DD | -0.17 |
EPS (Earnings per Share)
Revenue
Description: TU Telus March 05, 2026
TELUS Corporation (TU) is a Canadian telecommunications company. It provides mobile and fixed voice and data services, a core offering in the telecommunications sector.
The company operates through three main segments: TELUS Technology Solutions, TELUS Health, and TELUS Digital Experience. This diversified model extends beyond traditional telecom into areas like agriculture technology and healthcare services, which are growth areas for many telecom providers.
TELUS also offers data services, including internet, television, and cloud-based solutions. Additionally, it provides digital customer experience management and AI data services.
To deepen your understanding of TUs financial health and market position, consider exploring its detailed analytics on ValueRay.
Headlines to watch out for
- Wireless subscriber growth boosts telecom revenue
- Healthcare segment expansion drives new revenue streams
- Regulatory changes impact telecom pricing
- Capital expenditures for network upgrades affect profitability
- Economic downturn reduces consumer spending on services
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 1.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.62 > 1.0 |
| NWC/Revenue: -6.42% < 20% (prev -15.81%; Δ 9.39% < -1%) |
| CFO/TA 0.07 > 3% & CFO 4.44b > Net Income 1.11b |
| Net Debt (28.84b) to EBITDA (7.59b): 3.80 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.54b) vs 12m ago 3.42% < -2% |
| Gross Margin: 53.71% > 18% (prev 0.62%; Δ 5309 % > 0.5%) |
| Asset Turnover: 34.86% > 50% (prev 34.71%; Δ 0.15% > 0%) |
| Interest Coverage Ratio: 1.54 > 6 (EBITDA TTM 7.59b / Interest Expense TTM 1.52b) |
Altman Z'' 0.52
| A: -0.02 (Total Current Assets 8.37b - Total Current Liabilities 9.69b) / Total Assets 59.61b |
| B: 0.00 (Retained Earnings 98.0m / Total Assets 59.61b) |
| C: 0.04 (EBIT TTM 2.35b / Avg Total Assets 58.82b) |
| D: 0.37 (Book Value of Equity 15.88b / Total Liabilities 43.03b) |
| Altman-Z'' Score: 0.52 = B |
Beneish M -2.98
| DSRI: 0.97 (Receivables 4.25b/4.32b, Revenue 20.51b/20.14b) |
| GMI: 1.16 (GM 53.71% / 62.07%) |
| AQI: 0.96 (AQ_t 0.57 / AQ_t-1 0.59) |
| SGI: 1.02 (Revenue 20.51b / 20.14b) |
| TATA: -0.06 (NI 1.11b - CFO 4.44b) / TA 59.61b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of TU shares?
As of March 10, 2026, the stock is trading at USD 13.67 with a total of 8,828,697 shares traded.
Over the past week, the price has changed by +1.64%, over one month by -3.94%, over three months by +5.06% and over the past year by -8.07%.
Over the past week, the price has changed by +1.64%, over one month by -3.94%, over three months by +5.06% and over the past year by -8.07%.
Is TU a buy, sell or hold?
Telus has received a consensus analysts rating of 3.56.
Therefor, it is recommend to hold TU.
- StrongBuy: 3
- Buy: 5
- Hold: 9
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.8 | 23.1% |
| Analysts Target Price | 16.8 | 23.1% |
TU Fundamental Data Overview March 08, 2026
Market Cap CAD = 29.07b (21.39b USD * 1.3595 USD.CAD)
P/E Trailing = 26.3462
P/E Forward = 19.8807
P/S = 1.0511
P/B = 1.8779
P/EG = 1.4856
Revenue TTM = 20.51b CAD
EBIT TTM = 2.35b CAD
EBITDA TTM = 7.59b CAD
Long Term Debt = 27.44b CAD (from longTermDebt, last quarter)
Short Term Debt = 4.02b CAD (from shortTermDebt, last quarter)
Debt = 31.46b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.84b CAD (from netDebt column, last quarter)
Enterprise Value = 57.91b CAD (29.07b + Debt 31.46b - CCE 2.62b)
Interest Coverage Ratio = 1.54 (Ebit TTM 2.35b / Interest Expense TTM 1.52b)
EV/FCF = 23.51x (Enterprise Value 57.91b / FCF TTM 2.46b)
FCF Yield = 4.25% (FCF TTM 2.46b / Enterprise Value 57.91b)
FCF Margin = 12.01% (FCF TTM 2.46b / Revenue TTM 20.51b)
Net Margin = 5.43% (Net Income TTM 1.11b / Revenue TTM 20.51b)
Gross Margin = 53.71% ((Revenue TTM 20.51b - Cost of Revenue TTM 9.49b) / Revenue TTM)
Gross Margin QoQ = 28.66% (prev 61.67%)
Tobins Q-Ratio = 0.97 (Enterprise Value 57.91b / Total Assets 59.61b)
Interest Expense / Debt = 1.30% (Interest Expense 410.0m / Debt 31.46b)
Taxrate = 28.22% (114.0m / 404.0m)
NOPAT = 1.69b (EBIT 2.35b * (1 - 28.22%))
Current Ratio = 0.86 (Total Current Assets 8.37b / Total Current Liabilities 9.69b)
Debt / Equity = 1.99 (Debt 31.46b / totalStockholderEquity, last quarter 15.78b)
Debt / EBITDA = 3.80 (Net Debt 28.84b / EBITDA 7.59b)
Debt / FCF = 11.71 (Net Debt 28.84b / FCF TTM 2.46b)
Total Stockholder Equity = 14.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 1.11b / Total Assets 59.61b)
RoE = 7.68% (Net Income TTM 1.11b / Total Stockholder Equity 14.50b)
RoCE = 5.60% (EBIT 2.35b / Capital Employed (Equity 14.50b + L.T.Debt 27.44b))
RoIC = 3.61% (NOPAT 1.69b / Invested Capital 46.75b)
WACC = 3.54% (E(29.07b)/V(60.53b) * Re(6.35%) + D(31.46b)/V(60.53b) * Rd(1.30%) * (1-Tc(0.28)))
Discount Rate = 6.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.64%
[DCF] Terminal Value 88.43% ; FCFF base≈2.06b ; Y1≈2.54b ; Y5≈4.33b
[DCF] Fair Price = 62.27 (EV 126.04b - Net Debt 28.84b = Equity 97.20b / Shares 1.56b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -62.08 | EPS CAGR: -10.77% | SUE: -1.66 | # QB: 0
Revenue Correlation: 77.25 | Revenue CAGR: 6.50% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.15 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-5 | Analysts=10
EPS current Year (2026-12-31): EPS=0.68 | Chg7d=-0.077 | Chg30d=-0.076 | Revisions Net=-6 | Growth EPS=+1.0% | Growth Revenue=+2.5%
EPS next Year (2027-12-31): EPS=0.77 | Chg7d=-0.048 | Chg30d=-0.046 | Revisions Net=-1 | Growth EPS=+12.1% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = -2.2% (Analyst 1.9% - Implied 4.2%)
P/E Trailing = 26.3462
P/E Forward = 19.8807
P/S = 1.0511
P/B = 1.8779
P/EG = 1.4856
Revenue TTM = 20.51b CAD
EBIT TTM = 2.35b CAD
EBITDA TTM = 7.59b CAD
Long Term Debt = 27.44b CAD (from longTermDebt, last quarter)
Short Term Debt = 4.02b CAD (from shortTermDebt, last quarter)
Debt = 31.46b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.84b CAD (from netDebt column, last quarter)
Enterprise Value = 57.91b CAD (29.07b + Debt 31.46b - CCE 2.62b)
Interest Coverage Ratio = 1.54 (Ebit TTM 2.35b / Interest Expense TTM 1.52b)
EV/FCF = 23.51x (Enterprise Value 57.91b / FCF TTM 2.46b)
FCF Yield = 4.25% (FCF TTM 2.46b / Enterprise Value 57.91b)
FCF Margin = 12.01% (FCF TTM 2.46b / Revenue TTM 20.51b)
Net Margin = 5.43% (Net Income TTM 1.11b / Revenue TTM 20.51b)
Gross Margin = 53.71% ((Revenue TTM 20.51b - Cost of Revenue TTM 9.49b) / Revenue TTM)
Gross Margin QoQ = 28.66% (prev 61.67%)
Tobins Q-Ratio = 0.97 (Enterprise Value 57.91b / Total Assets 59.61b)
Interest Expense / Debt = 1.30% (Interest Expense 410.0m / Debt 31.46b)
Taxrate = 28.22% (114.0m / 404.0m)
NOPAT = 1.69b (EBIT 2.35b * (1 - 28.22%))
Current Ratio = 0.86 (Total Current Assets 8.37b / Total Current Liabilities 9.69b)
Debt / Equity = 1.99 (Debt 31.46b / totalStockholderEquity, last quarter 15.78b)
Debt / EBITDA = 3.80 (Net Debt 28.84b / EBITDA 7.59b)
Debt / FCF = 11.71 (Net Debt 28.84b / FCF TTM 2.46b)
Total Stockholder Equity = 14.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 1.11b / Total Assets 59.61b)
RoE = 7.68% (Net Income TTM 1.11b / Total Stockholder Equity 14.50b)
RoCE = 5.60% (EBIT 2.35b / Capital Employed (Equity 14.50b + L.T.Debt 27.44b))
RoIC = 3.61% (NOPAT 1.69b / Invested Capital 46.75b)
WACC = 3.54% (E(29.07b)/V(60.53b) * Re(6.35%) + D(31.46b)/V(60.53b) * Rd(1.30%) * (1-Tc(0.28)))
Discount Rate = 6.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.64%
[DCF] Terminal Value 88.43% ; FCFF base≈2.06b ; Y1≈2.54b ; Y5≈4.33b
[DCF] Fair Price = 62.27 (EV 126.04b - Net Debt 28.84b = Equity 97.20b / Shares 1.56b; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -62.08 | EPS CAGR: -10.77% | SUE: -1.66 | # QB: 0
Revenue Correlation: 77.25 | Revenue CAGR: 6.50% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.15 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-5 | Analysts=10
EPS current Year (2026-12-31): EPS=0.68 | Chg7d=-0.077 | Chg30d=-0.076 | Revisions Net=-6 | Growth EPS=+1.0% | Growth Revenue=+2.5%
EPS next Year (2027-12-31): EPS=0.77 | Chg7d=-0.048 | Chg30d=-0.046 | Revisions Net=-1 | Growth EPS=+12.1% | Growth Revenue=+2.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 7.9% - Earnings Yield 3.8%)
[Growth] Growth Spread = -2.2% (Analyst 1.9% - Implied 4.2%)